Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Slides: 1–12 of 71
Add to tray Remove from tray

Background: Musculoskeletal Pain

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | children | clinical characteristics | stiffness | joint swelling | malar rash | cytopenia | pediatric rheumatic condition
Add to tray Remove from tray

Background: Juvenile Idiopathic Arthritis

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: juvenile idiopathic arthritis | chronic inflammatory disease | disease progression | cartilage | bone | soft tissue | severe disability | functional loss | organ failure | death
Study Population. A study shows that the use of a new medication in male astronauts, 25 to 35 years of age, prevents bone mineral density loss during prolonged stays in outer space when compared with no therapy. Which factors would limit the applicability of this trial to patients with osteoporosis? A. Differences in gender and age between the study population and the general population. B. Use of a surrogate end point. C. Differences in setting between the study population and the general population. D. All of the above.
Add to tray Remove from tray

Study Population

Presentation: Assessing Applicability Quiz
Add to tray Remove from tray

Comparative Effectiveness Review: Outcomes of Interest

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: adverse events | head and neck cancer | outcomes | quality of life | radiotherapy | tumor control | xerostomia | comparative effectiveness review
Add to tray Remove from tray

Evidence on the Comparative Effectiveness Regarding Quality of Life and Adverse Events

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: 3DCRT | adverse events | head and neck cancer | IMRT | outcomes | quality of life | radiotherapy | comparative effectiveness
This slide graphically presents numerical differences in late xerostomia reported by seven different reports comparing IMRT vs. 3DCRT. The difference in percentages of adverse avents that occurred with IMRT vs. 3DCRT ranged from 7% to 79%. Four studies found large (greater than 15 percentage points) significant differences favoring IMRT over 3DCRT in the frequency of late xerostomia.
Add to tray Remove from tray

Studies Regarding Quality of Life and Adverse Events: IMRT vs. 3DCRT

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: 3DCRT | adverse events | head and neck cancer | IMRT | outcomes | quality of life | radiotherapy | xerostomia | comparative effectiveness
Add to tray Remove from tray

Evidence on the Comparative Effectiveness Regarding Quality of Life and Adverse Events: IMRT vs. 2DRT

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: 2DRT | adverse events | head and neck cancer | IMRT | outcomes | quality of life | radiotherapy | xerostomia | comparative effectiveness
This slide graphically presents numerical differences in the incidence of late xerostomia reported by nine different reports comparing IMRT vs. 2DRT. The difference in percentages of adverse avents that occurred with IMRT vs. 2DRT ranged from 43% to 62%. Consistent between-group differences were found for two outcomes: late xerostomia and health-related quality of life domains related to xerostomia.Eight were statistically significant in favor of IMRT.
Add to tray Remove from tray

Studies Regarding Late Xerostomia: IMRT vs. 2DRT

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: 2DRT | adverse events | head and neck cancer | IMRT | outcomes | quality of life | radiotherapy | xerostomia | comparative effectiveness
Add to tray Remove from tray

Evidence on the Comparative Effectiveness Regarding Quality of Life and Adverse Events: 3DCRT vs. 2DRT

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: 2DRT | 3DCRT | adverse events | head and neck cancer | outcomes | quality of life | radiotherapy | comparative effectiveness
Add to tray Remove from tray

Findings of the Comparative Effectiveness Review: Medication (3 of 3)

Presentation: Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update
Keywords: GERD | histamine type 2 receptor antagonist | H2RA | proton pump inhibitor | PPI | extraesophageal
Add to tray Remove from tray

Overview of Adverse Events and Side Effects

Presentation: Comparing Medications for Adults With Type 2 Diabetes
Keywords: congestive heart failure | fracture | gastrointestinal | hypoglycemia | metformin | second-generation sulfonylureas | side effect | thiazolidinedione | adverse event
Add to tray Remove from tray

Other Adverse Events and Side Effects: Comparisons of Monotherapies

Presentation: Comparing Medications for Adults With Type 2 Diabetes
Keywords: adverse events | congestive heart failure | fractures | lactic acidosis | monotherapy | liver injury
Pages: [1] 2 3 4 5 6 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364